Lee Financial’s Royalty Pharma RPRX Stock Holding History

Lee Financial’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,300	Closed	-$36.5K	–	678
2023 Q4	$36.5K	Hold	1,300	–	–	0.01%	259
2023 Q3	$35.3K	Hold	1,300	–	–	0.01%	252
2023 Q2	$40K	Hold	1,300	–	–	0.01%	239
2023 Q1	$46.8K	Sell	1,300 -60	-4%	-$2.23K	0.01%	235
2022 Q4	$53.7K	Hold	1,360	–	–	0.01%	247
2022 Q3	$54K	Sell	1,360 -4	-0.3%	-$171	0.01%	245
2022 Q2	$58K	Buy	1,364 +64	+5%	+$2.62K	0.01%	234
2022 Q1	$51K	Hold	1,300	–	–	0.01%	240
2021 Q4	$52K	Hold	1,300	–	–	0.01%	252
2021 Q3	$47K	Hold	1,300	–	–	0.01%	231
2021 Q2	$53K	Hold	1,300	–	–	0.01%	223
2021 Q1	$57K	Hold	1,300	–	–	0.01%	223
2020 Q4	$65K	Buy	+1,300	New	+$55.2K	0.02%	189

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return